Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) EBT Margin (2022 - 2025)

HCW Biologics (HCWB) has disclosed EBT Margin for 4 consecutive years, with 22044.68% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin fell 2112824.0% year-over-year to 22044.68%, compared with a TTM value of 3017.89% through Sep 2025, down 194627.0%, and an annual FY2024 reading of 1173.09%, down 25817.0% over the prior year.
  • EBT Margin was 22044.68% for Q3 2025 at HCW Biologics, up from 56053.05% in the prior quarter.
  • Across five years, EBT Margin topped out at 60.33% in Q1 2022 and bottomed at 56053.05% in Q2 2025.
  • Average EBT Margin over 4 years is 9569.56%, with a median of 813.2% recorded in 2023.
  • The sharpest move saw EBT Margin soared 1235692bps in 2024, then tumbled -5358144bps in 2025.
  • Year by year, EBT Margin stood at 429.49% in 2022, then tumbled by -89bps to 813.2% in 2023, then decreased by -6bps to 861.87% in 2024, then tumbled by -2458bps to 22044.68% in 2025.
  • Business Quant data shows EBT Margin for HCWB at 22044.68% in Q3 2025, 56053.05% in Q2 2025, and 43862.27% in Q1 2025.